Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab

MeSH terms

• Adenocarcinoma / drug therapy
• Adenocarcinoma / secondary
• Adenocarcinoma / surgery
• Adenocarcinoma / therapy*
• Antibodies, Bispecific / administration & dosage
• Antibodies, Bispecific / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Carcinoma / diagnosis*
• Chemotherapy, Adjuvant
• Clinical Trials, Phase II as Topic
• Diagnosis, Differential
• Gastrectomy
• Humans
• Infusions, Intravenous
• Infusions, Parenteral
• Intraoperative Period
• Male
• Middle Aged
• Neoplasm Staging
• Peritoneal Neoplasms / diagnosis*
• Peritoneal Neoplasms / secondary
• Peritonitis / chemically induced
• Peritonitis / diagnosis*
• Postoperative Period
• Stomach Neoplasms / drug therapy
• Stomach Neoplasms / pathology
• Stomach Neoplasms / surgery
• Stomach Neoplasms / therapy*
• Tomography, X-Ray Computed
• Treatment Outcome